Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Aug 15, 2016
Clinical News

Halaven eribulin mesylate regulatory update

BioCentury | May 30, 2016
Clinical News

Halaven eribulin mesylate: Phase III data

BioCentury | May 16, 2016
Clinical News

Halaven eribulin mesylate regulatory update

BioCentury | Apr 25, 2016
Clinical News

Halaven eribulin mesylate regulatory update

BioCentury | Mar 7, 2016
Clinical News

Eribulin mesylate regulatory update

BioCentury | Feb 8, 2016
Clinical News

Halaven eribulin mesylate regulatory update

BioCentury | Oct 5, 2015
Clinical News

Eribulin mesylate regulatory update

BioCentury | Mar 2, 2015
Clinical News

Eribulin mesylate: Phase III data

Items per page:
1 - 10 of 59